BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4278354)

  • 1. Toxicity of halogenated oxyquinolines in dogs. A clinical study. IV. Tissue distribution and elimination in urine.
    Lannek B; Lindberg P
    Acta Vet Scand; 1974; 15(3):419-35. PubMed ID: 4278354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity of halogenated oxyquinolines in dogs. A clinical study. 3. Intoxication experiments.
    Lannek B; Lindberg P
    Acta Vet Scand; 1974; 15(3):398-418. PubMed ID: 4278355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ distribution and metabolism of radioactive iodochlorohydroxyquinoline (clioquinol, chinoform) in animals.
    Ogata M; Watanabe S; Tateishi J; Kuroda S; Kira S
    Folia Psychiatr Neurol Jpn; 1974; 28(3):243-57. PubMed ID: 4279877
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies of the distribution and excretion of clioquinol in the animal.
    Schmid K; Krinke G; Früh F; Keberle H
    Arzneimittelforschung; 1973 Nov; 23(11):1560-6. PubMed ID: 4273865
    [No Abstract]   [Full Text] [Related]  

  • 5. Toxicity of halogenated oxyquinolines to dogs. The effect of feeding fouled herring.
    Lannek B; Lindberg P
    Acta Vet Scand; 1972; 13(3):441-2. PubMed ID: 4264058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enterohepatic circulation of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1984 Jun; 7(6):420-5. PubMed ID: 6237189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of 14C-iodochlorhydroxyquin in the dog and the rat.
    Jurima M; Kalow W; Inaba T
    J Pharmacobiodyn; 1984 Mar; 7(3):164-70. PubMed ID: 6235361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous absorption of clioquinol (Vioform).
    Degen PH; Moppert J; Schmid K; Weirich EG
    Dermatologica; 1979; 159(4):295-301. PubMed ID: 157893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous absorption and disposition of iodochlorhydroxyquin in dogs.
    Ezzedeen FW; Stohs SJ; Kilzer KL; Makoid MC; Ezzedeen NW
    J Pharm Sci; 1984 Oct; 73(10):1369-72. PubMed ID: 6239025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clioquinol toxicity in the dog.
    Worden AN; Heywood R; Prentice DE; Chesterman H; Skerrett K; Thomann PE
    Toxicology; 1978 Mar; 9(3):227-38. PubMed ID: 148753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal absorption and metabolism of clioquinol in the rat.
    Kotaki H; Yamamura Y; Tanimura Y; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1983 Nov; 6(11):881-7. PubMed ID: 6230438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various effects of halogenated oxyquinolines inducing neurotoxic symptoms in the animal organism].
    Zeiller P; Sensch KH; Dahme E
    Arzneimittelforschung; 1972 Aug; 22(8):1307-12. PubMed ID: 4264180
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex difference of the metabolic disposition of clioquinol in rats.
    Ohshima N; Kotaki H; Saitoh Y; Nakagawa F; Tamura Z
    J Pharmacobiodyn; 1989 Jul; 12(7):371-7. PubMed ID: 2531797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of 125-iodochloroxyquinoline in man. I. Absorption, binding and excretion.
    Liewendahl K; Lamberg BA
    Nucl Med (Stuttg); 1967 Mar; 6(1):20-31. PubMed ID: 4174558
    [No Abstract]   [Full Text] [Related]  

  • 15. The oral toxicity of clioquinol (5-chloro-7-iodo-8-hydroxyquinoline) in beagle dogs.
    Heywood R; Chesterman H; Worden AN
    Toxicology; 1976 Jun; 6(1):41-6. PubMed ID: 133475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoradiographic distribution of 131I-clioquinol in beagle dogs.
    Tateishi J; Kuroda S; Watanabe S; Otsuki S; Ogata M
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):73-6. PubMed ID: 4275985
    [No Abstract]   [Full Text] [Related]  

  • 17. Various factors affecting intestinal absorption of iodochlorhydroxyquin in rat and man.
    Hayashi M; Fuwa T; Awazu S; Hanano M
    Chem Pharm Bull (Tokyo); 1976 Nov; 24(11):2603-9. PubMed ID: 138487
    [No Abstract]   [Full Text] [Related]  

  • 18. Percutaneous absorption of iodochlorhydroxyquin in humans.
    Stohs SJ; Ezzedeen FW; Anderson AK; Baldwin JN; Makoid MC
    J Invest Dermatol; 1984 Feb; 82(2):195-8. PubMed ID: 6229586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clioquinol: absence of neurotoxicity in laboratory animals.
    Hess R; Keberle H; Koella WP; Schmid K; Gelzer J
    Lancet; 1972 Aug; 2(7774):424-5. PubMed ID: 4115240
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of green pigment and analysis of clioquinol in specimens from patients with subacute myelo-optico-neuropathy.
    Tamura Z; Yoshioka M; Imanari T; Fukaya J; Kusaka J
    Clin Chim Acta; 1973 Aug; 47(1):13-20. PubMed ID: 4270607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.